Summary
Updated Aug 30, 2026
Reid G. Adler is Chief Legal Officer of Vistagen Therapeutics, Inc. (VTGN). 3 SEC Form 4 filings on record going back to 2025, most recently on 2 July 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Reid G. Adler has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Reid G. Adler's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Stephen M. Bloch - $118.66M of LQDA open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $117.62M of ARTV open-market activity in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M of RLAY open-market activity in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M of HTFL open-market activity in the last 12 months
- Herriot Tabuteau - $110.58M of AXSM open-market activity in the last 12 months
- Mayukh Sukhatme - $109.13M of ROIV open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Reid G. Adler?
Reid G. Adler is a corporate insider, tracked as Chief Legal Officer of Vistagen Therapeutics, Inc. (VTGN). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Reid G. Adler submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Reid G. Adler's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Reid G. Adler and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
